| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 11.02. | TIANJIN PHARMACEUTICAL DA REN TANG GROUP CORPORATION LIMITED: WAIVER::WAIVER ANNOUNCEMENT | 8 | SGX Company Announcements | ||
| 05.02. | TIANJIN PHARMACEUTICAL DA REN TANG GROUP CORPORATION LIMITED: DISCLOSURE OF INTEREST/CHANGES IN INTEREST OF SUBSTANTIAL SHAREHOLDER(S)/UNITHOLDER(S)::INCREASE IN S-SHARES BY CONTROLLING SHAREHOLDER | 1 | SGX Company Announcements | ||
| 05.02. | TIANJIN PHARMACEUTICAL DA REN TANG GROUP CORPORATION LIMITED: DISCLOSURE OF INTEREST/CHANGES IN INTEREST OF DIRECTOR/CHIEF EXECUTIVE OFFICER::INCREASE IN S-SHARES BY CONTROLLING SHAREHOLDER | 3 | SGX Company Announcements | ||
| 05.02. | TIANJIN PHARMACEUTICAL DA REN TANG GROUP CORPORATION LIMITED: GENERAL ANNOUNCEMENT::INCREASE IN S-SHARES BY CONTROLLING SHAREHOLDER AND PROPOSED SHAREHOLDING INCREASE PLAN | 2 | SGX Company Announcements | ||
| TIANJIN PHARMACEUTICAL DA REN TANG Aktie jetzt für 0€ handeln | |||||
| 02.02. | TIANJIN PHARMACEUTICAL DA REN TANG GROUP CORPORATION LIMITED: REPL::CASH DIVIDEND/DISTRIBUTION::MANDATORY | - | SGX Company Announcements | ||
| 30.01. | TIANJIN PHARMACEUTICAL DA REN TANG GROUP CORPORATION LIMITED: GENERAL ANNOUNCEMENT::MONTHLY UPDATE ON BANKRUPTCY LIQUIDATION OF A SUBSIDIARY OF THE COMPANY | 2 | SGX Company Announcements | ||
| 28.01. | TIANJIN PHARMACEUTICAL DA REN TANG GROUP CORPORATION LIMITED: CHANGE - ANNOUNCEMENT OF APPOINTMENT::ANNOUNCEMENT OF APPOINTMENT | 2 | SGX Company Announcements | ||
| 23.01. | TIANJIN PHARMACEUTICAL DA REN TANG GROUP CORPORATION LIMITED: CASH DIVIDEND/DISTRIBUTION::MANDATORY | 6 | SGX Company Announcements | ||
| 12.01. | TIANJIN PHARMACEUTICAL DA REN TANG GROUP CORPORATION LIMITED: GENERAL ANNOUNCEMENT::MINUTES OF THE 2ND EXTRAORDINARY GENERAL MEETING OF THE COMPANY FOR FY2025 HELD ON 15 DECEMBER 2025 | 1 | SGX Company Announcements | ||
| 31.12.25 | TIANJIN PHARMACEUTICAL DA REN TANG GROUP CORPORATION LIMITED: GENERAL ANNOUNCEMENT::MONTHLY UPDATE ON BANKRUPTCY LIQUIDATION OF A SUBSIDIARY OF THE COMPANY | 1 | SGX Company Announcements | ||
| 15.12.25 | TIANJIN PHARMACEUTICAL DA REN TANG GROUP CORPORATION LIMITED: CHANGE - ANNOUNCEMENT OF CESSATION::ANNOUNCEMENT OF CESSATION | 1 | SGX Company Announcements | ||
| 15.12.25 | TIANJIN PHARMACEUTICAL DA REN TANG GROUP CORPORATION LIMITED: REPL::EXTRAORDINARY/SPECIAL GENERAL MEETING::VOLUNTARY | 1 | SGX Company Announcements | ||
| 09.12.25 | TIANJIN PHARMACEUTICAL DA REN TANG GROUP CORPORATION LIMITED: REPL::EXTRAORDINARY/SPECIAL GENERAL MEETING::VOLUNTARY | 2 | SGX Company Announcements | ||
| 28.11.25 | TIANJIN PHARMACEUTICAL DA REN TANG GROUP CORPORATION LIMITED: REPL::EXTRAORDINARY/SPECIAL GENERAL MEETING::VOLUNTARY | 1 | SGX Company Announcements | ||
| 28.11.25 | TIANJIN PHARMACEUTICAL DA REN TANG GROUP CORPORATION LIMITED: GENERAL ANNOUNCEMENT::MONTHLY UPDTAE ON BANKRUPTCY LIQUIDATION OF A SUBSIDIARY OF THE COMPANY | 1 | SGX Company Announcements | ||
| 25.11.25 | TIANJIN PHARMACEUTICAL DA REN TANG GROUP CORPORATION LIMITED: GENERAL ANNOUNCEMENT::ANNOUNCEMENT ON RECEIPT OF DRUG REGISTRATION CERTIFICATE | - | SGX Company Announcements | ||
| 24.11.25 | TIANJIN PHARMACEUTICAL DA REN TANG GROUP CORPORATION LIMITED: GENERAL ANNOUNCEMENT::ANNOUNCEMENT ON CONVENING AN ONLINE CONFERENCE | 1 | SGX Company Announcements | ||
| 30.10.25 | TIANJIN PHARMACEUTICAL DA REN TANG GROUP CORPORATION LIMITED: EXTRAORDINARY/SPECIAL GENERAL MEETING::VOLUNTARY | - | SGX Company Announcements | ||
| 30.10.25 | TIANJIN PHARMACEUTICAL DA REN TANG GROUP CORPORATION LIMITED: GENERAL ANNOUNCEMENT::AMENDMENTS TO THE ARTICLES OF ASSOCIATION OF THE COMPANY | - | SGX Company Announcements | ||
| 30.10.25 | TIANJIN PHARMACEUTICAL DA REN TANG GROUP CORPORATION LIMITED: GENERAL ANNOUNCEMENT::RESOLUTIONS PASSED AT THE 6TH BOARD MEETING FOR FY2025 | - | SGX Company Announcements |
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| ASTRAZENECA | 174,45 | +0,49 % | DEUTSCHE BANK RESEARCH stuft ASTRAZENECA auf 'Sell' | FRANKFURT (dpa-AFX Analyser) - Deutsche Bank Research hat die Einstufung für Astrazeneca mit einem Kursziel von 11500 Pence auf "Sell" belassen. Das maue vierte Quartal der Briten sei durch einen soliden... ► Artikel lesen | |
| TEVA | 28,700 | -1,37 % | FDA Accepts NDA For Teva And Medincell's Olanzapine LAI In Schizophrenia Treatment | PETAH TIKVA (dpa-AFX) - Teva Pharmaceuticals, the U.S. affiliate of Teva Pharmaceutical Industries Ltd. (TEVA), together with Medincell, announced that the U.S. Food and Drug Administration... ► Artikel lesen | |
| SINOPHARM | 2,262 | -1,05 % | Sinopharm Group-Aktie heute gut behauptet: Aktienwert steigt (2,08 €) | Der Anteilsschein der Sinopharm Group notiert heute ein wenig fester. Zuletzt zahlten Investoren für das Wertpapier 2,08 Euro. Jahreschart der Sinopharm Group Ltd-Aktie, Stand 11.09.2025 Freuen können... ► Artikel lesen | |
| CSPC PHARMA | 1,130 | -1,31 % | CSPC PHARMA (01093): VOLUNTARY ANNOUNCEMENT - GLP-1/GIP RECEPTOR DUAL-BIASED AGONIST POLYPEPTIDE LONG-ACTING INJECTION (SYH2082 INJECTION) OBTAINS CLINICAL ... | ||
| WUXI BIOLOGICS | 4,370 | -0,46 % | BRIEF: CANbridge raises $26 million in share sale to WuXi Bio at 14.7% discount | ||
| OPKO HEALTH | 1,023 | 0,00 % | Can OPKO Health's Pipeline Progress and Deals Drive Growth in 2026? | ||
| SHANGHAI FOSUN PHARMACEUTICAL | 2,152 | -1,01 % | Milliarden für Metsera & Fosun Pharma: Pfizers Schicksalsjahre beginnen | Die Pfizer-Aktie steht aktuell bei 21 EUR - ein Niveau, das die Unsicherheit der letzten zwei Jahre widerspiegelt. Nach dem steilen Absturz der COVID-Umsätze kämpft der Pharmariese darum, sein Portfolio... ► Artikel lesen | |
| GEDEON RICHTER | 30,240 | 0,00 % | Gedeon Richter Plc.: Extraordinary Information | ||
| DR REDDYS | 12,000 | -3,23 % | Dr. Reddy's biosimilar for Bristol's Orencia undergoes FDA review | ||
| THC BIOMED | 0,011 | 0,00 % | XFRA DELETION OF INSTRUMENTS FROM BOERSE FRANKFURT - 23.09.2025 | The following instruments on Boerse Frankfurt do have their last trading day on 23.09.2025.Die folgenden Instrumente in Boerse Frankfurt haben ihren letzten Handelstag am 23.09.2025.ISIN NameAU0000221251 LEO... ► Artikel lesen | |
| BAYER | 43,680 | -4,16 % | Bayer-Aktie steigt weiter: Das sind die nächsten Chartmarken | Positive Nachrichten aus der Produkt-Pipeline und Fortschritte in Rechtsstreitigkeien um Glyphosat treiben seit Wochen die Bayer-Aktie an. Anleger bauen bei dem DAX-Titel auf den charttechnischen Befreiungsschlag.... ► Artikel lesen | |
| MERCK KGAA | 128,15 | +0,20 % | EQS-PVR: Merck KGaA: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution | EQS Voting Rights Announcement: Merck KGaA
Merck KGaA: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide... ► Artikel lesen | |
| NOVO NORDISK | 40,370 | +0,15 % | Novo Nordisk: Analysten wittern Chance auf Comeback | Novo Nordisk zeigt nach deutlichen Verlusten auf Jahressicht erste Anzeichen einer Stabilisierung über der 40-Euro-Marke, doch von einer nachhaltigen Trendwende kann noch keine Rede sein. Besonders... ► Artikel lesen | |
| PENTIXAPHARM | 2,350 | +1,08 % | PENTIXAPHARM HOLDING AG festigt ihre Stärke | ||
| GSK | 25,320 | -0,35 % | BERENBERG stuft GSK auf 'Hold' | HAMBURG (dpa-AFX Analyser) - Die Privatbank Berenberg hat das Kursziel für GSK von 1660 auf 2000 Pence angehoben, aber die Einstufung auf "Hold" belassen. Die Aktien der Briten seien im Pharmasektor... ► Artikel lesen |